Found: 598
Select item for more details and to access through your institution.
Large-scale aggregate data for left bundle branch area pacing as first line for CRT: climbing the pyramid of evidence.
- Published in:
- Journal of Interventional Cardiac Electrophysiology, 2024, v. 67, n. 6, p. 1293, doi. 10.1007/s10840-024-01827-6
- By:
- Publication type:
- Article
44. Jahrestagung der Österreichischen Diabetes Gesellschaft. "Chancen und Risiken für Menschen mit Diabetes".
- Published in:
- Wiener Klinische Wochenschrift, 2016, v. 128, p. 395, doi. 10.1007/s00508-016-1101-y
- Publication type:
- Article
Tandem positive action of SGLT2 inhibitors and ARNI in patients with heart failure.
- Published in:
- 2021
- By:
- Publication type:
- Letter
The effects of saxagliptin on cardiac structure and function using cardiac MRI (SCARF).
- Published in:
- Acta Diabetologica, 2021, v. 58, n. 5, p. 633, doi. 10.1007/s00592-020-01661-y
- By:
- Publication type:
- Article
Integrative System Biology Analyses Identify Seven MicroRNAs to Predict Heart Failure.
- Published in:
- Non-Coding RNA, 2019, v. 5, n. 1, p. 1, doi. 10.3390/ncrna5010022
- By:
- Publication type:
- Article
Beneficiile preparatelor antihipertensive la pacienţii cu hipertensiune arterială și glaucom.
- Published in:
- Farmacist.ro, 2022, n. 1, p. 22
- By:
- Publication type:
- Article
Role of Phosphodiesterase 1 in the Regulation of Real-Time cGMP Levels and Contractility in Adult Mouse Cardiomyocytes.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 23, p. 2759, doi. 10.3390/cells12232759
- By:
- Publication type:
- Article
CD10-Bound Human Mesenchymal Stem/Stromal Cell-Derived Small Extracellular Vesicles Possess Immunomodulatory Cargo and Maintain Cartilage Homeostasis under Inflammatory Conditions.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 14, p. 1824, doi. 10.3390/cells12141824
- By:
- Publication type:
- Article
Seminal-Plasma-Mediated Effects on Sperm Performance in Humans.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 14, p. N.PAG, doi. 10.3390/cells11142147
- By:
- Publication type:
- Article
Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 3, p. 414, doi. 10.3390/cells11030414
- By:
- Publication type:
- Article
Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 10, p. 2796, doi. 10.3390/cells10102796
- By:
- Publication type:
- Article
Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 3, p. 534, doi. 10.3390/cells10030534
- By:
- Publication type:
- Article
Effect of Interventions in WNT Signaling on Healing of Cardiac Injury: A Systematic Review.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 2, p. 207, doi. 10.3390/cells10020207
- By:
- Publication type:
- Article
The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 9, p. 2134, doi. 10.3390/cells9092134
- By:
- Publication type:
- Article
The Network of Angiotensin Receptors in Breast Cancer.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 6, p. 1336, doi. 10.3390/cells9061336
- By:
- Publication type:
- Article
Live-Cell Cardiac-Specific High-Throughput Screening Platform for Drug-Like Molecules That Enhance Ca2+ Transport.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 5, p. 1170, doi. 10.3390/cells9051170
- By:
- Publication type:
- Article
Alterations in Glucose Metabolism During the Transition to Heart Failure: The Contribution of UCP-2.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 3, p. 552, doi. 10.3390/cells9030552
- By:
- Publication type:
- Article
Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 2, p. 452, doi. 10.3390/cells9020452
- By:
- Publication type:
- Article
Intracerebral Injection of Extracellular Vesicles from Mesenchymal Stem Cells Exerts Reduced Aβ Plaque Burden in Early Stages of a Preclinical Model of Alzheimer's Disease.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 9, p. 1059, doi. 10.3390/cells8091059
- By:
- Publication type:
- Article
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1402782
- By:
- Publication type:
- Article
Impact of baseline kidney function on the effects of sodium‐glucose co‐transporter‐2 inhibitors on kidney and heart failure outcomes: A systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1341, doi. 10.1111/dom.14986
- By:
- Publication type:
- Article
Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 2017, doi. 10.1111/dom.14789
- By:
- Publication type:
- Article
Mediators of the effects of canagliflozin on N‐terminal pro‐brain natriuretic peptide concentration: An exploratory mediation analysis of the randomized CANDLE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 962, doi. 10.1111/dom.14656
- By:
- Publication type:
- Article
The comparative cardiovascular and renal effectiveness of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A Scandinavian cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 3, p. 473, doi. 10.1111/dom.14598
- By:
- Publication type:
- Article
Challenges and opportunities in real‐world evidence on the renal effects of sodium‐glucose cotransporter‐2 inhibitors.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 177, doi. 10.1111/dom.14599
- By:
- Publication type:
- Article
Cardiovascular and microvascular outcomes with iGlarLixi versus iDegLira: A real‐world, population‐based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 348, doi. 10.1111/dom.14579
- By:
- Publication type:
- Article
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 125, doi. 10.1111/dom.14558
- By:
- Publication type:
- Article
Are novel glucose‐lowering agents' cardiorenal benefits generalizable to individuals of Black race? A meta‐trial sequential analysis to address disparities in cardiovascular and renal outcome trials enrolment.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 154, doi. 10.1111/dom.14540
- By:
- Publication type:
- Article
Biologically plausible trends suggesting that a low‐protein diet may enhance the effect of flozination caused by the sodium‐glucose cotransporter‐2 inhibitor dapagliflozin on albuminuria.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2825, doi. 10.1111/dom.14524
- By:
- Publication type:
- Article
Lower risk of hospitalization for heart failure, kidney disease and death with sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease: A retrospective cohort study in UK primary care
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2207, doi. 10.1111/dom.14437
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors and protection from cardiovascular death: Is it all about heart failure?
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 9, p. 2194, doi. 10.1111/dom.14444
- By:
- Publication type:
- Article
Dapagliflozin reduces systolic blood pressure and modulates vasoactive factors.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1614, doi. 10.1111/dom.14377
- By:
- Publication type:
- Article
Lower heart failure and chronic kidney disease risks associated with sodium‐glucose cotransporter‐2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, p. 19, doi. 10.1111/dom.14119
- By:
- Publication type:
- Article
Lower heart failure and chronic kidney disease risks associated with sodium‐glucose cotransporter‐2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, p. 19, doi. 10.1111/dom.14119
- By:
- Publication type:
- Article
The impact of the glucagon-like peptide-1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2141, doi. 10.1111/dom.14135
- By:
- Publication type:
- Article
Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: Pooled analysis of randomized active controlled clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1556, doi. 10.1111/dom.14067
- By:
- Publication type:
- Article
The effects of dapagliflozin on cardio‐renal risk factors in patients with type 2 diabetes with or without renin‐angiotensin system inhibitor treatment: a post hoc analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 549, doi. 10.1111/dom.13923
- By:
- Publication type:
- Article
Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti‐hyperglycaemic drug matters?
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 149, doi. 10.1111/dom.13881
- By:
- Publication type:
- Article
Use of sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2354, doi. 10.1111/dom.13819
- By:
- Publication type:
- Article
Critical role of the epicardium in mediating cardiac inflammation and fibrosis in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 8, p. 1765, doi. 10.1111/dom.13792
- By:
- Publication type:
- Article
Decreases in neprilysin and vasoconstrictors and increases in vasodilators following bariatric surgery.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 2029, doi. 10.1111/dom.13320
- By:
- Publication type:
- Article
Neprilysin expression in pancreatic cells plays a protective role against pancreatic cell dysfunction.
- Published in:
- African Journal of Diabetes Medicine, 2023, v. 31, n. 2, p. 1
- By:
- Publication type:
- Article
Blood–brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01132-2
- By:
- Publication type:
- Article
The dopaminergic system promotes neprilysin-mediated degradation of amyloid-β in the brain.
- Published in:
- Science Signaling, 2024, v. 17, n. 848, p. 1, doi. 10.1126/scisignal.adk1822
- By:
- Publication type:
- Article
Sacubitril/Valsartan: potential treatment for paediatric heart failure.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impaired hepatic amyloid-beta degradation in Alzheimer’s disease.
- Published in:
- PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0203659
- By:
- Publication type:
- Article
Profound loss of neprilysin accompanied by decreased levels of neuropeptides and increased CRP in ulcerative colitis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0189526
- By:
- Publication type:
- Article
Paramount Importance of Angiotensin ReceptorNeprilysin Inhibitor in Heart Failure Management.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Heart Failure Council of Thailand (HFCT) 2019 Heart Failure Guideline: Pharmacologic Treatment of Chronic Heart Failure - Part I.
- Published in:
- Journal of the Medical Association of Thailand, 2019, v. 102, n. 2, p. 1
- By:
- Publication type:
- Article
IGFs and IGF-Binding Proteins in the Synovial Fluid of Patients with Rheumatoid Arthritis and Osteoarthritis.
- Published in:
- International Journal of Peptide Research & Therapeutics, 2020, v. 26, n. 1, p. 271, doi. 10.1007/s10989-019-09835-1
- By:
- Publication type:
- Article